Picture of Celltrion Healthcare Co logo

091990 — Celltrion Healthcare Co News Story

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousLarge Cap

Brief: Celltrion USA Receives U.S. FDA Approval For Its Oncology Biosimilar Vegzelma For Treatment Of Six Types Of Cancer

Sept 28 (Reuters) - Celltrion Healthcare Co Ltd
 091990.KQ :
    * CELLTRION USA RECEIVES U.S. FDA APPROVAL FOR ITS ONCOLOGY
BIOSIMILAR VEGZELMA® (BEVACIZUMAB-ADCD) FOR THE TREATMENT OF SIX
TYPES OF CANCER
    * CELLTRION USA- APPROVAL BASED ON TOTALITY OF EVIDENCE WITH
NO
CLINICALLY MEANINGFUL DIFFERENCES IN EFFICACY OR SAFETY WITH
REFERENCE PRODUCT AVASTIN

Source text for Eikon:  ID:nBwbtVvWka 
Further company coverage:  091990.KQ 
 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Celltrion Healthcare Co

See all news